These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4571897)

  • 21. A comparison of use of carbohydrate, cell structure, and toxin formation in naturally occurring and thymine-requiring Staphylococcus aureus strains.
    de Repentigny J; Mathieu LG
    Can J Microbiol; 1971 Nov; 17(11):1343-50. PubMed ID: 4110000
    [No Abstract]   [Full Text] [Related]  

  • 22. Tryptophan metabolism and toxin formation in Staphylococcus aureus Wood 46 strain.
    Leboeuf-Trudeau T; de Repentigny J; Frenette RM; Sonea S
    Can J Microbiol; 1969 Jan; 15(1):1-7. PubMed ID: 4975315
    [No Abstract]   [Full Text] [Related]  

  • 23. The amino acid-fermenting clostridia.
    Mead GC
    J Gen Microbiol; 1971 Jul; 67(1):47-56. PubMed ID: 5124513
    [No Abstract]   [Full Text] [Related]  

  • 24. Yeast mutant requiring an organic solvent for growth.
    Karst F; Lacroute F
    J Gen Microbiol; 1974 Nov; 85(1):1-10. PubMed ID: 4612101
    [No Abstract]   [Full Text] [Related]  

  • 25. Production of staphylococcal alpha toxin. II. Glucose repression of toxin formation.
    Duncan JL; Cho GJ
    Infect Immun; 1972 Nov; 6(5):689-94. PubMed ID: 4564783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological properties of alpha-toxin mutants of Staphylococcus aureus.
    McClatchy JK; Rosenblum ED
    J Bacteriol; 1966 Sep; 92(3):575-9. PubMed ID: 5922533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and some properties of staphylococcal alpha-toxin.
    Watanabe M; Kato I
    Jpn J Exp Med; 1974 Apr; 44(2):165-78. PubMed ID: 4546168
    [No Abstract]   [Full Text] [Related]  

  • 28. [Production of lysozyme and toxins of staphylococcal strains from animals].
    Hussels H; Langmaack H; Grossgebauer K; Förster D
    Zentralbl Bakteriol Orig; 1970; 214(2):203-6. PubMed ID: 4991449
    [No Abstract]   [Full Text] [Related]  

  • 29. "Dysgonic" strains of mycobacterium tuberculosis on Ogawa's egg medium isolated as pathogens from patients suffering from lung tuberculosis. II. Growth-inhibitory effects of D-asparagine, D-aspartic acid, Dl-serine, or L-serine against "dysgonic".
    Ujiie A; Nemoto G; Kinoshita Y
    Jpn J Tuberc; 1967 Dec; 14(3):116-28. PubMed ID: 4970396
    [No Abstract]   [Full Text] [Related]  

  • 30. Amino acid requirements of Eikenella corrodens.
    Keudell KC; Robertson NL; Gilles P
    Microbios; 1986; 47(191):73-81. PubMed ID: 3097459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of amino acids on the growth of Acetobacter suboxydans.
    Belly RT; Claus GW
    Arch Mikrobiol; 1972; 83(3):237-45. PubMed ID: 5026267
    [No Abstract]   [Full Text] [Related]  

  • 32. Germination of spores of Clostridium bifermentans by certain amino acids, lactate and pyruvate in the presence of sodium or potassium ions.
    Waites WM; Wyatt LR
    J Gen Microbiol; 1971 Aug; 67(2):215-22. PubMed ID: 5132277
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of amino acids on zinc-65 incorporation by Ehrlich ascites tumor cells in vitro.
    Kuroda Y
    Gan; 1967 Oct; 58(5):481-3. PubMed ID: 6082823
    [No Abstract]   [Full Text] [Related]  

  • 34. Free amino acids in E.L.4 mouse ascites tumor cells taken from susceptible (C57BL) and resistant (B10.D2) mice.
    Wein J; Roberts E; Fox M; Weinstein C
    Cancer Res; 1973 Nov; 33(11):2987-92. PubMed ID: 4795908
    [No Abstract]   [Full Text] [Related]  

  • 35. Amino acid requirements for growth of the rabbit blastocyst in vitro.
    Daniel JC; Krishnan RS
    J Cell Physiol; 1967 Oct; 70(2):155-60. PubMed ID: 5625908
    [No Abstract]   [Full Text] [Related]  

  • 36. Some properties of glutamine synthetase from baker's yeast.
    Hachimori A; Ito M; Samejima T
    J Biochem; 1974 Nov; 76(5):1075-81. PubMed ID: 4156034
    [No Abstract]   [Full Text] [Related]  

  • 37. A chemically defined medium for the production of staphylococcal beta hemolysin.
    Sharma BS; Haque R
    Can J Microbiol; 1973 Oct; 19(10):1319-23. PubMed ID: 4762801
    [No Abstract]   [Full Text] [Related]  

  • 38. Lysogenic conversion of staphylococci to loss of beta-toxin.
    Winkler KC; de Waart J; Grootsen C
    J Gen Microbiol; 1965 Jun; 39(3):321-33. PubMed ID: 4222155
    [No Abstract]   [Full Text] [Related]  

  • 39. Amino acid supplementation improves heterologous protein production by Saccharomyces cerevisiae in defined medium.
    Görgens JF; van Zyl WH; Knoetze JH; Hahn-Hägerdal B
    Appl Microbiol Biotechnol; 2005 Jun; 67(5):684-91. PubMed ID: 15630584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Toxin and enzyme formation by staphylococci of various origins].
    Sytnik IA
    Mikrobiol Zh; 1978; 40(5):613-8. PubMed ID: 723677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.